BIONANO GENOMICS INC (BNGO:NASDAQ)
$1.2 0.06 (5.2632%)
Analysed BIONANO GENOMICS INC (BNGO:NASDAQ) News Sources
Bionano Genomics, Inc. Q1 2026 Earnings Call Summary
14-05-2026
moby.co
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
20-05-2026
yahoo.com
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia
26-05-2026
yahoo.com
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures
28-05-2026
yahoo.com
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors
28-05-2026
yahoo.com
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock?
08-06-2026
yahoo.com
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders
11-06-2026
yahoo.com
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
18-06-2026
yahoo.com
Bionano Announces Hiring of Chief Scientific Officer
24-06-2026
yahoo.com
Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer
06-07-2026
yahoo.com
What is the current price of BIONANO GENOMICS INC (BNGO:NASDAQ)?
The current price of BIONANO GENOMICS INC (BNGO:NASDAQ) is $1.2.
BIONANO GENOMICS INC (BNGO:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIONANO GENOMICS INC (BNGO:NASDAQ) since the previous trading day is $0.06.
BIONANO GENOMICS INC (BNGO:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIONANO GENOMICS INC (BNGO:NASDAQ) since the previous trading day is 5.2632%.
What is the most recent average sentiment score for BIONANO GENOMICS INC (BNGO:NASDAQ)?
The most recent average sentiment score for BIONANO GENOMICS INC (BNGO:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for BIONANO GENOMICS INC (BNGO:NASDAQ)?
The most recent sentiment for BIONANO GENOMICS INC (BNGO:NASDAQ) is .
SEC-8K** Filing Available For BIONANO GENOMICS INC (BNGO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.